Keywords: Tumors (Post-Treatment), Spectroscopy
Motivation: Metabolic characteristics related to treatment in patients with Lower-grade gliomas (LrGG) can improve survival outcomes and quality of life.
Goal(s): The goal of this study was to evaluate longitudinal changes in metabolite ratios of pre-treated LrGG patients who received no further treatment.
Approach: The study uses quantified metabolite ratios obtained from 3D MRSI in an existing LrGG cohort and statistically compared those ratios across different pre-treatment groups and baseline.
Results: Although all treatment groups show no statistically significant differences at 3 time points, two treatment groups display significant changes of metabolite ratios at 6 months and past 24 months.
Impact: Results of this study can provide insight into if different treatments can impact a patient’s neurocognitive function that is tied with metabolite profile. The finding can also provide suggestions on when re-treatment is recommended for patients with LrGG.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords